Snowball logo
logo
ACHL

Achilles Therapeutics plc American Depositary Shares

ACHL • NASDAQ Не торгуется
-- $0,00 $  (0%)
Оценка
EPS
-1,66
Прогноз
EPS (FWD)
-0,12
Другое
Размер лота
1 шт.
О компании
Тикер
ACHL
ISIN
US00449L1026
Страна
Великобритания
Сектор (GICS)
Здравоохранение
Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.

Часто задаваемые вопросы

В каком секторе работает Achilles Therapeutics plc American Depositary Shares (ACHL)?

Achilles Therapeutics plc American Depositary Shares относится к сектору Здравоохранение.

Выплачивает ли Achilles Therapeutics plc American Depositary Shares (ACHL) дивиденды?

Нет, Achilles Therapeutics plc American Depositary Shares не выплачивает дивиденды.